首页> 美国卫生研究院文献>Therapeutic Advances in Neurological Disorders >Comparable efficacy and safety of dimethyl fumarate and teriflunomidetreatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-wordmulticenter experience

【2h】

Comparable efficacy and safety of dimethyl fumarate and teriflunomidetreatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-wordmulticenter experience

机译：富马酸二甲酯和特氟米特的相对疗效和安全性复发性多发性硬化症的临床治疗：意大利语实词多中心体验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:The aim of the study was to evaluate the achievement of ‘no evidence of disease activity’ (NEDA) over a 12-month period in a large multicenter population with relapsing remitting multiple sclerosis (RRMS) treated with delayed-release dimethyl fumarate (DMF) and teriflunomide (TRF) using a propensity-score adjustment.

机译：背景：这项研究的目的是评估使用延缓释放富马酸二甲酯治疗的多发性反复多发性硬化症（RRMS）的大型多中心人群在12个月内实现的“无疾病活动证据”（NEDA）的实现（ DMF）和特立氟胺（TRF）使用倾向评分调整。

著录项

期刊名称 Therapeutic Advances in Neurological Disorders
作者
Emanuele D’Amico; Aurora Zanghì; Graziella Callari; Giovanna Borriello; Antonio Gallo; Giusi Graziano; Paola Valentino; Maria Buccafusca; Salvatore Cottone; Giuseppe Salemi; Paolo Ragonese; Roberto Bruno Bossio; Renato Docimo; Luigi Maria Edoardo Grimaldi; Carlo Pozzilli; Gioacchino Tedeschi; Mario Zappia; Francesco Patti;
展开▼
作者单位

展开▼
年(卷),期 2018(11),-1
年度 2018
页码 1756286418796404
总页数 14
原文格式 PDF
正文语种
中图分类神经科学 ;
关键词
dimethyl fumarate efficacy no evidence of disease activity 3 safety teriflunomide;

机译：富马酸二甲酯;功效;无疾病活动证据3;安全性;特立氟胺;

相似文献

外文文献
中文文献
专利

1. Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience [J] . Emanuele D’Amico, Aurora Zanghì, Graziella Callari, Therapeutic advances in neurological disorders. . 2018 ,第11期

机译：富马酸二甲酯和特氟米特治疗复发缓解型多发性硬化症的可比疗效和安全性：意大利实词多中心经验
2. Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience [J] . DAmico Emanuele, Zanghi Aurora, Callari Graziella, Therapeutic advances in neurological disorders. . 2018 ,第Jana期

机译：富马酸二甲酯和三氟甘油酯治疗在复发 - 饲料多发性硬化中的相当疗效和安全性：意大利实际多中心经验
3. Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence [J] . Bhavya Narapureddy, Divyanshu Dubey Patient Preference and Adherence . 2019 ,第1期

机译：富马酸二甲酯治疗复发缓解型多发性硬化症的临床评估：疗效，安全性，患者经验和依从性
4. Microstructural Modulations in the Hippocampus Allow to Characterizing Relapsing-Remitting Versus Primary Progressive Multiple Sclerosis [C] . Lorenza Brusini, Ilaria Boscolo Galazzo, Muge Akinci, International Workshop on Brain-Lesion;Medical Image Computing and Computer Assisted Intervention Conference . 2020

机译：海马中的微观结构调制允许表征复发 - 延长与初级进步多发性硬化
5. Mesenchymal Stem Cell-derived Exosomes Ameliorate Disease in a Model of Relapsing-remitting Multiple Sclerosis [D] . Yuan, Oliver 2018

机译：间充质干细胞源性外来体改善复发-释放性多发性硬化症模型中的疾病。
6. Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis [O] . Nasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar, 2021

机译：Teriflunomide的相当功效和安全性与富马酸二甲烷的富马酸盐进行治疗重复多发性硬化
7. Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis [O] . Raed Alroughani, Peter Huppke, Maria Mazurkiewicz-Beldzinska, 2021

机译：延迟释放的二甲基富马酸骨果实安全性和疗效在分泌延迟多发性硬化症

Comparable efficacy and safety of dimethyl fumarate and teriflunomidetreatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-wordmulticenter experience

摘要

著录项

相似文献

相关主题

期刊订阅